Compare Citius Pharmaceuticals Inc (CTXR) vs Matson Inc (MATX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Matson Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Matson Inc trades at $207.76 (market cap $6.11B). The key difference: Matson Inc is far larger — about 305.3× Citius Pharmaceuticals Inc's market cap, and Matson Inc pays a 0.74% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | MATX | |
|---|---|---|
Market Cap | $20.01M | $6.11B |
Sector | Health | Technology |
52-Week High | $1.82 | $223.55 |
52-Week Low | $0.48 | $88.05 |
Enterprise Value | $16.23M | $6.71B |
Dividend Yield | — | 0.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Matson Inc
Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.
Read more on MATX →
